{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:15:56Z","timestamp":1784337356774,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omtm.2022.12.013","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T14:33:58Z","timestamp":1672238038000},"page":"190-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-5199","authenticated-orcid":false,"given":"Richard","family":"Dambra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlynn","family":"Graca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed Salehin","family":"Akhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurin","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee","family":"Bell-Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyue","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bunosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Maugiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey M.","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Fogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-2783","authenticated-orcid":false,"given":"Joseph","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.12.013_bib1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtm.2022.12.013_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2020.01.039","article-title":"Review of talimogene laherparepvec: a first-in-class oncolytic viral treatment of advanced melanoma","volume":"83","author":"Haitz","year":"2020","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.omtm.2022.12.013_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"Russell","year":"2014","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.omtm.2022.12.013_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cancers12061416","article-title":"Efficacy and safety of oncolytic viruses in randomized controlled trials: a systematic review and meta-analysis","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omtm.2022.12.013_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtm.2020.01.001","article-title":"Oncolytic viruses and the immune system: the dynamic duo","volume":"17","author":"Lemos de Matos","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.12.013_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/fvl-2016-0129","article-title":"Designing and building oncolytic viruses","volume":"12","author":"Maroun","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biomedicines5010003","article-title":"Taking a stab at cancer; oncolytic virus-mediated anti-cancer vaccination strategies","volume":"5","author":"Aitken","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2022.12.013_bib8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1099\/vir.0.046672-0","article-title":"Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer","volume":"93","author":"Hastie","year":"2012","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib9","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/jgv.0.000980","article-title":"Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update","volume":"98","author":"Felt","year":"2017","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib10","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.3390\/molecules23123310","article-title":"Self-replicating RNA viruses for RNA therapeutics","volume":"23","author":"Lundstrom","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.omtm.2022.12.013_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines5010008","article-title":"Oncolytic vesicular stomatitis virus as a viro-immunotherapy: defeating cancer with a \u201chammer\u201d and \u201canvil\u201d","volume":"5","author":"Melzer","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2022.12.013_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-006-0042-3","article-title":"Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector","volume":"28","author":"Clarke","year":"2006","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.omtm.2022.12.013_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2013.11.010","article-title":"Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer","volume":"132","author":"Liu","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.omtm.2022.12.013_bib14","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ymthe.2017.05.006","article-title":"Oncolytic VSV primes differential responses to immuno-oncology therapy","volume":"25","author":"Durham","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/humc.2016.061","article-title":"Safety studies in tumor and non-tumor-bearing mice in support of clinical trials using oncolytic VSV-IFN-\u03b2-NIS","volume":"27","author":"Zhang","year":"2016","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2022.12.013_bib16","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2012.70","article-title":"Curative one-shot systemic virotherapy in murine myeloma","volume":"26","author":"Naik","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2022.12.013_bib17","doi-asserted-by":"crossref","first-page":"e14637","DOI":"10.1200\/JCO.2017.35.15_suppl.e14637","article-title":"Phase I study of oncolytic virus (OV) MG1 maraba\/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced\/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214","volume":"35","author":"Jonker","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtm.2022.12.013_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/1535-7163.MCT-17-0432","article-title":"Comparative oncology evaluation of intravenous recombinant oncolytic Vesicular Stomatitis Virus therapy in spontaneous canine cancer","volume":"17","author":"Naik","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib19","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1016\/S2152-2650(21)01935-2","article-title":"TCL-461: clinical activity of systemic VSV-IFN\u03b2-NIS oncolytic virotherapy in patients with relapsed refractory hematologic malignancies","volume":"21","author":"Cook","year":"2021","journal-title":"Clin. Lymphoma, Myeloma\u00a0& Leukemia"},{"key":"10.1016\/j.omtm.2022.12.013_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtm.2020.08.017","article-title":"Nonclinical studies that support viral vector-delivered gene therapies: an EFPIA gene therapy working group perspective","volume":"19","author":"Bolt","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.12.013_bib21","series-title":"Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products","year":"2013"},{"key":"10.1016\/j.omtm.2022.12.013_bib22","doi-asserted-by":"crossref","first-page":"e1002281","DOI":"10.1371\/journal.ppat.1002281","article-title":"Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium","volume":"7","author":"Ganesan","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2022.12.013_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/humc.2013.165","article-title":"Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs","volume":"24","author":"LeBlanc","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2022.12.013_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4049\/jimmunol.85.1.99","article-title":"Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice","volume":"85","author":"Brunner","year":"1960","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1128\/JVI.74.2.644-651.2000","article-title":"Large-plaque mutants of sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation","volume":"74","author":"Byrnes","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib26","doi-asserted-by":"crossref","first-page":"705443","DOI":"10.3389\/fphar.2021.705443","article-title":"Mechanistic modeling of a novel oncolytic virus, V937, to describe viral kinetic and dynamic processes following intratumoral and intravenous administration","volume":"12","author":"Parra-Guillen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtm.2022.12.013_bib27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/JVI.78.2.912-921.2004","article-title":"PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum","volume":"78","author":"Croyle","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib28","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/0022-1317-81-11-2605","article-title":"Blood clearance rates of adenovirus type 5 in mice","volume":"81","author":"Alemany","year":"2000","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib29","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow","volume":"15","author":"Breitbach","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/hum.2020.114","article-title":"Systematic characterization of the biodistribution of the oncolytic virus M1","volume":"31","author":"Cai","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/nnm-2019-0323","article-title":"Designer nanocarriers for navigating the systemic delivery of oncolytic viruses","volume":"15","author":"Howard","year":"2020","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.omtm.2022.12.013_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.12.013_bib33","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1128\/JVI.02052-09","article-title":"Vesicular stomatitis virus genomic RNA persists in\u00a0vivo in the absence of viral replication","volume":"84","author":"Simon","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.12.013_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.cgt.7700948","article-title":"Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model","volume":"13","author":"Peng","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/OV.S137159","article-title":"The importance of imaging strategies for pre-clinical and clinical in\u00a0vivo distribution of oncolytic viruses","volume":"7","author":"Pelin","year":"2018","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.omtm.2022.12.013_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4939-9794-7_15","article-title":"Oncolytic viruses in\u00a0vivo bioimaging for monitoring intratumoral virus activity","volume":"2058","author":"Schreiber","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2022.12.013_bib38","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1038\/s41598-021-81831-2","article-title":"Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs","volume":"11","author":"B\u00e9guin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.12.013_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gt.2013.84","article-title":"In\u00a0vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models","volume":"21","author":"Jing","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib40","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2009.03.006","article-title":"In\u00a0vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation","volume":"27","author":"Johnson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2022.12.013_bib41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1089\/104303403322495070","article-title":"Biodistribution of oncolytic measles virus after intraperitoneal administration into ifnar-CD46Ge transgenic mice","volume":"14","author":"Peng","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2016.11.003","article-title":"A generic viral dynamic model to systematically characterize the interaction between oncolytic virus kinetics and tumor growth","volume":"97","author":"Titze","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.omtm.2022.12.013_bib43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2022.12.013_bib44","first-page":"401","article-title":"Basic concepts of pharmacokinetic\/pharmacodynamic (PK\/PD) modelling","volume":"35","author":"Meibohm","year":"1997","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2022.12.013_bib45","series-title":"European Medicines Agency Committee for Medicinal Products for Human Use","year":"2015"},{"key":"10.1016\/j.omtm.2022.12.013_bib46","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/s41467-021-25506-6","article-title":"A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity","volume":"12","author":"Das","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.12.013_bib48","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.2217\/fon-2022-0439","article-title":"Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors","volume":"18","author":"Porosnicu","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.omtm.2022.12.013_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/jvi.30.3.746-753.1979","article-title":"Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis","volume":"30","author":"Weck","year":"1979","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib50","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.152155599","article-title":"Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome","volume":"99","author":"Whelan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2022.12.013_bib51","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.1039\/C6CP00865H","article-title":"Direct measurement of the tryptophan-mediated photocleavage kinetics of a protein disulfide bond","volume":"18","author":"Abaskharon","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.omtm.2022.12.013_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0042-6822(88)90633-2","article-title":"Alteration of vesicular stomatitis virus L and NS proteins by uv irradiation: implications for the mechanism of host cell shut-off","volume":"164","author":"Whitaker-Dowling","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.omtm.2022.12.013_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/jvi.13.3.729-739.1974","article-title":"Effect of ultraviolet light on mengovirus: formation of uracil dimers, instability and degradation of capsid, and covalent linkage of protein to viral RNA","volume":"13","author":"Miller","year":"1974","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of \u03b1-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.12.013_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.200104103","article-title":"Molecular analysis of the interaction of LCMV with its cellular receptor \u03b1-dystroglycan","volume":"155","author":"Kunz","year":"2001","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2022.12.013_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.187.4.649","article-title":"Induction of protective cytotoxic T\u00a0cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization","volume":"187","author":"Seiler","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2022.12.013_bib57","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20051557","article-title":"Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread","volume":"203","author":"Hangartner","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2022.12.013_bib58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vetmic.2012.08.023","article-title":"Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus","volume":"162","author":"Zimmer","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.omtm.2022.12.013_bib59","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1128\/JVI.79.16.10376-10385.2005","article-title":"Early alpha\/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88","volume":"79","author":"Hidmark","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib60","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/JVI.78.4.1706-1717.2004","article-title":"Innate cellular response to virus particle entry requires IRF3 but not virus replication","volume":"78","author":"Collins","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib90","series-title":"Morphometric (Organ Weight) Survey of 11 Strains of Mice","author":"Denegre","year":"2007"},{"key":"10.1016\/j.omtm.2022.12.013_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cell.2009.01.019","article-title":"The many pathways of RNA degradation","volume":"136","author":"Houseley","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2022.12.013_bib63","doi-asserted-by":"crossref","first-page":"a016378","DOI":"10.1101\/cshperspect.a016378","article-title":"Sinusoidal immunity: macrophages at the lymphohematopoietic interface","volume":"7","author":"Gordon","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omtm.2022.12.013_bib64","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3389\/fimmu.2018.02472","article-title":"CD169+ macrophages capture and dendritic cells instruct: the interplay of the gatekeeper and the general of the immune system","volume":"9","author":"Grabowska","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ni.2169","article-title":"Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus","volume":"13","author":"Honke","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fimmu.2019.00347","article-title":"Lymph node subcapsular sinus macrophages as the frontline of lymphatic immune defense","volume":"10","author":"Louie","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib67","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3389\/fmicb.2019.01490","article-title":"RNA synthesis and capping by non-segmented negative strand RNA viral polymerases: lessons from a prototypic virus","volume":"10","author":"Ogino","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtm.2022.12.013_bib68","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1016\/j.vaccine.2019.08.037","article-title":"A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine","volume":"37","author":"Hankaniemi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2022.12.013_bib69","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0264-410X(94)00054-Q","article-title":"Antigenicity of hepatitis A virus after ultra-violet inactivation","volume":"13","author":"Wang","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.omtm.2022.12.013_bib70","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/AEM.02773-15","article-title":"Comparison of UV-induced inactivation and RNA damage in MS2 phage across the germicidal UV spectrum","volume":"82","author":"Beck","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.omtm.2022.12.013_bib71","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1099\/0022-1317-72-7-1611","article-title":"High resolution in\u00a0situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence","volume":"72","author":"Fazakerley","year":"1991","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/355696a0","article-title":"Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix","volume":"355","author":"Ibraghimov-Beskrovnaya","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.12.013_bib73","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.12.013_bib74","doi-asserted-by":"crossref","first-page":"1959140","DOI":"10.1080\/2162402X.2021.1959140","article-title":"Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants","volume":"10","author":"Pipperger","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.omtm.2022.12.013_bib75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1369\/0022155411410885","article-title":"Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery","volume":"59","author":"Shi","year":"2011","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2022.12.013_bib76","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtm.2022.12.013_bib77","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1016\/j.bmc.2017.06.040","article-title":"Nanoparticle-macrophage interactions: a balance between clearance and cell-specific targeting","volume":"25","author":"Rattan","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtm.2022.12.013_bib78","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1055\/s-0041-109631","article-title":"Balancing viral replication in spleen and liver determines the outcome of systemic virus infection","volume":"53","author":"Lang","year":"2015","journal-title":"Z.\u00a0Gastroenterol."},{"key":"10.1016\/j.omtm.2022.12.013_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.23640","article-title":"Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice","volume":"52","author":"Lang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2022.12.013_bib80","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/eji.1830271023","article-title":"Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection","volume":"27","author":"Seiler","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib81","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.169.3.1453","article-title":"Marginal zone macrophages and immune responses against viruses","volume":"169","author":"Oehen","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib82","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fimmu.2019.00778","article-title":"Sources of type I interferons in infectious immunity: plasmacytoid dendritic cells not always in the driver\u2019s seat","volume":"10","author":"Ali","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.12.013_bib83","doi-asserted-by":"crossref","first-page":"e2446","DOI":"10.1038\/cddis.2016.350","article-title":"CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection","volume":"7","author":"Shaabani","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtm.2022.12.013_bib84","doi-asserted-by":"crossref","first-page":"805629","DOI":"10.1155\/2012\/805629","article-title":"Systemic delivery of oncolytic viruses: hopes and hurdles","volume":"2012","author":"Ferguson","year":"2012","journal-title":"Adv. Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib85","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.7150\/thno.34509","article-title":"Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans","volume":"9","author":"Valic","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.omtm.2022.12.013_bib86","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/JVI.02511-10","article-title":"Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism","volume":"85","author":"Muik","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.12.013_bib87","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1158\/0008-5472.CAN-13-3306","article-title":"Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency","volume":"74","author":"Muik","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2022.12.013_bib88","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394C T method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omtm.2022.12.013_bib89","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays","volume":"11","author":"Hamilton","year":"1977","journal-title":"Environ. Sci. Technol."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122001863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122001863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:30:28Z","timestamp":1762421428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050122001863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":88,"alternative-id":["S2329050122001863"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.12.013","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022","name":"copyright","label":"Copyright"}]}}